Dindigul Farm Product Limited received in-principal listing approval from BSE SME

Mumbai (Maharashtra) [India], June 3: Dindigul Farm Products Limited is primarily engaged in processing of Whole milk and skimmed milk to make dairy ingredients including milk protein concentrates, skimmed milk powder, dairy whitener, whey protein concentrate, milk whey powder, casein, unbranded cream, butter and fat-filled powders for infant milk formula. The processing facility is situated at Dindigul, Tamil Nadu, India and is spread over 15 acres.

Dindigul Farm Product Limited has filed the Draft Red Herring Prospectus with BSE SME for raising funds through a public offer. The company will issue fresh equity shares of 64,50,000.

Dindigul Farm Product Limited IPO objectives:

The company plans to allocate the net proceeds from the issue to the following purposes:

  1. Funding Capital Expenditure
  2. To meet working capital requirement
  3. General Corporate Purpose

Book Running Lead Manager to the Issue is Beeline Capital Advisors Private Limited, and the Registrar to the Issue is Link Intime India Private Limited.

If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.

aayush jain acquisition Business cashew processing cote d’ivoire esos 2026 pacific global fzco Pajson Agro pulkit jain Royal Mewa Share Swap

From Local to Global: Pajson Agro India to Acquire Pacific Global FZCO, Adding 60,000 MT Capacity at the World’s Largest Cashew Origin

All-stock 100% acquisition | ₹354.52 crore | Board also approves ESOS 2026 New Delhi [India], November 6: Pajson Agro India Limited (PAJSON | 544657 | INE14LM01012), a vertically integrated cashew processing company with farm-gate sourcing across key producing origins and a growing consumer brand, ‘Royal Mewa’, has announced that its Board of Directors, has approved […]

Read More
Business Fredun Pharmaceuticals EBITDA Growth Fredun Pharmaceuticals H1 FY27 Results Fredun Pharmaceuticals Net Profit Fredun Pharmaceuticals Revenue Growth Indian pharmaceutical industry

Fredun Pharmaceuticals On A Growth Overdrive: Net Profit Soars 94%, Ebitda Rockets 92% And Revenue Surges 87% In H1 Fy27

Mumbai (Maharashtra) [India], November 6: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), one of India’s leading pharmaceutical formulation manufacturing companies, has announced its unaudited financial results for Q2 & H1 FY27. The Company offers a diversified portfolio spanning generics, cosmeceuticals, nutraceuticals, mobility solutions, and animal healthcare products. Key Financial Highlights Standalone key Financial Highlights […]

Read More
aluminium castings BSE SME earnings exports Finance H1 FY27 results Indian stock market karjan vadodara swastika castal swastikaal varun sharda

Swastika Castal Delivers Robust H1 FY27; Net Profit Surges 30%, Total Income Up 24% YoY

Vadodara (Gujarat) [India], November 6: Swastika Castal Limited (BSE – SWASTIKAAL | 544452), an established manufacturer of high-precision aluminium castings with integrated manufacturing capabilities and growing global export presence, has reported its unaudited financial results for H1 FY27. Standalone Key Financial Highlights – H1 FY27 Total Income: ₹21.25 Cr, up 24% YoY. EBITDA: ₹3.34 Cr, […]

Read More